MANILA, Philippines — The Department of Science and Technology (DOST) has confirmed the signing of a letter of agreement for the conduct of the World Health Organization’s (WHO) solidarity trials...
MANILA, Philippines — The Department of Science and Technology (DOST) cannot confirm yet whether virgin coconut oil (VCO) can treat COVID-19 based on current studies being conducted. DOST Philippine Council...
MANILA, Philippines — The Department of Science and Technology (DOST) announced that it is launching a study into the mixing and matching of COVID-19 vaccine brands. DOST Undersecretary Rowena Guevara...
MANILA, Philippines – Department of Science and Technology (DOST) Secretary Fortunato dela Peña said that preparations are underway for the anticipated clinical trials on the use of ivermectin as a...
MANILA, Philippines—There is no need to conduct clinical trials in the Philippines for ivermectin, according to the Department of Science and Technology (DOST). The DOST’s Philippine Council for Health Research...
MANILA, Philippines — The Department of Science and Technology (DOST) believes that it is possible for the Philippines to become a vaccine manufacturer. During the ‘Kapihan sa Manila Bay’ on...
MANILA, Philippines — The national government assures that experts are carefully studying the available efficacy and safety data of every developed vaccine specifically against coronavirus disease (COVID-19) from any manufacturer....
MANILA, Philippines — The Department of Science and Technology’s (DOST) STAMINA4Space Program announced on Monday (December 14) that the 4th Joint Global Multi-Nation Birds Satellite or BIRDS-4 project is now...
MANILA, Philippines — A research study conducted in Singapore and funded by the Department of Science and Technology, has revealed the potential of virgin coconut oil or VCO, in treating...
MANILA, Philippines – The Department of Science and Technology (DOST) on Tuesday announced that 13 hospitals will be involved in the solidarity trials of the World Health Organization (WHO) for...
